Stock listing

OTC:ALUR Allurion Technologies, Inc. Stock

Follow Allurion Technologies, Inc. into a list and get an email when it puts out news.

Share price · OTC:ALUR

$0.0021 USD 0.0000 (0.0%)

Close on Nov 18, 2026

Past year -100.0% · daily closes, Jun 18, 2026 – Nov 18, 2026, adjusted for splits
Day range
$0.0021 – $0.0021 USDNov 18, 2026
Volume
463 sharesNov 18, 2026
Market cap
—Left out: price × shares is far from the company's reported size
Traded on an average day
$2,881 USDMedian day 736 shares · 9 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026

Daily closes

Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:ALUR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00210.00000.0%$0.0021$0.0021$0.0021463
$0.0021+0.0001+5.0%$0.0007$0.0021$0.0007418
$0.00200.00000.0%$0.0020$0.0020$0.00201,305
$0.00200.00000.0%$0.0020$0.0020$0.0020199
$0.0020-0.0001-4.8%$0.0020$0.0020$0.0020307
$0.0021+0.0011+110.0%$0.0020$0.0021$0.0020726
$0.0010-0.0004-28.6%$0.0010$0.0010$0.0010294
$0.0014-0.0191-93.2%$0.0009$0.0014$0.00091,815
$0.0205+0.0105+105.0%$0.0100$0.0205$0.0100746
$0.0100-0.0055-35.5%$0.0100$0.0100$0.0100302
$0.0155-0.4595-96.7%$0.0155$0.0155$0.0155403
$0.47500.00000.0%$0.4750$0.4750$0.47500
$0.47500.00000.0%$0.4750$0.4750$0.47500
$0.47500.00000.0%$0.4750$0.4750$0.47500
$0.47500.00000.0%$0.4750$0.4750$0.47500
$0.47500.00000.0%$0.4750$0.4750$0.47500
$0.4750-0.1250-20.8%$0.4750$0.4750$0.4750200
$0.6000+0.0830+16.1%$0.4000$0.6000$0.400011,800
$0.5170+0.0070+1.4%$0.5170$0.5170$0.51701,700
$0.5100-0.0530-9.4%$0.4000$0.5800$0.40008,000
$0.5630+0.1130+25.1%$0.5630$0.5630$0.5630300
$0.4500-0.0510-10.2%$0.4590$0.4590$0.40006,000
$0.5010+0.0090+1.8%$0.5800$0.5800$0.434011,600
$0.4920+0.0020+0.4%$0.4920$0.4920$0.4920200
$0.4900-0.1100-18.3%$0.4900$0.4900$0.4900300
$0.6000-0.1770-22.8%$0.6240$0.6900$0.60006,100
$0.7770-0.2730-26.0%$0.9520$0.9520$0.733010,200
$1.05000.00000.0%$1.0500$1.0500$1.05000
$1.0500-0.0560-5.1%$1.1420$1.1420$1.0500500
$1.1060-0.0040-0.4%$1.1300$1.1300$1.1060300
$1.11000.00000.0%$1.1100$1.1100$1.11000
$1.1100-0.0400-3.5%$1.1100$1.1100$1.11004,800
$1.1500+0.1300+12.7%$1.0500$1.1500$1.0500400
$1.02000.00000.0%$1.0200$1.0200$1.02000
$1.0200-0.0300-2.9%$1.0700$1.0800$1.02001,600
$1.0500-0.1400-11.8%$1.0300$1.0500$1.01006,300
$1.1900+0.0300+2.6%$1.1500$1.1900$1.1500200
$1.1600-0.0860-6.9%$1.2100$1.2100$1.16001,400
$1.2460+0.0370+3.1%$1.2460$1.2460$1.2460300
$1.20900.00000.0%$1.2090$1.2090$1.20900
$1.2090+0.0390+3.3%$1.1300$1.2090$1.13001,100
$1.1700-0.0450-3.7%$1.2100$1.2100$1.14004,800
$1.2150-0.0650-5.1%$1.2000$1.2600$1.20001,600
$1.2800+0.1600+14.3%$1.1200$1.3710$1.120014,000
$1.1200+0.0200+1.8%$1.0920$1.1200$1.09201,800
$1.1000-0.0700-6.0%$1.2000$1.2000$1.1000500
$1.1700-0.3300-22.0%$1.1800$1.1800$1.1700400
$1.5000+0.1200+8.7%$1.3800$1.5500$1.38002,300
$1.3800-0.0700-4.8%$1.4500$1.4500$1.3800500
$1.4500+0.0900+6.6%$1.6890$1.6950$1.45001,900
$1.3600-0.3900-22.3%$1.7500$1.8320$1.36005,200
$1.7500-0.0200-1.1%$1.7500$1.7500$1.75001,100
$1.7700-0.2400-11.9%$1.7000$1.9000$1.70001,500
$2.0100-0.0550-2.7%$2.0500$2.0500$1.70001,600
$2.0650+0.1150+5.9%$2.1900$2.1900$2.02001,500
$1.9500-0.3400-14.8%$2.2000$2.2000$1.80003,200
$2.2900-0.4700-17.0%$2.5600$2.7000$1.990014,000
$2.7600-0.6420-18.9%$3.3900$3.3900$2.51008,800

Splits

2 splits since 2025 · OTC:ALUR · every price before a split is adjusted for it

DayRatioWhat
1-for-15Consolidation
1-for-25Consolidation
Ticker
OTC:ALUR
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

What changed lately

Allurion Technologies, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
Calls
8 calls with a replay · 8 with a transcript · latest Nov 13, 2026
Decks
3 decks · latest Jun 26, 2024

Valuation

Statements: 4 quarters to Mar 31, 2026 · price Nov 18, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
52.7%
Operating margin
−211.2%
Net margin
−264.7%
Debt to equity
Negative equity
Beta vs S&P 500
-0.42

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
82.50 USD · Analysts' mean
EPS, year to Dec 2026
-20.25 · 1 analyst

Team and board

Officers

OfficerRole
Shantanu GaurChief Executive Officer and Co-Founder
Ojas A. BuchChief Operating Officer
Brendan GibbonsChief Legal Officer
Ram Chuttani M.DChief Medical Officer and Founding Partner

Board

DirectorRole
Douglas HudsonDirector
Keith JohnsDirector
Krishna K. GuptaDirector
Michael DavinDirector
Nicholas LewinDirector
Omar IshrakBoard Member
R. Jason RicheyDirector

Events

Results days

QuarterResults
Q1 2026May 20, 2026
Q4 2025Mar 19, 2026
Q3 2025Nov 12, 2025
Q2 2025Aug 19, 2025
Q1 2025May 15, 2025
Q4 2024Mar 27, 2025
Q3 2024Nov 13, 2024 · Before open
Q2 2024Aug 13, 2024 · Before open
Q1 2024May 14, 2024 · Before open
Q4 2023Mar 26, 2024 · After close
All 19 quarters
QuarterResults
Q3 2023Nov 29, 2023
Q1 2023Apr 4, 2023
Q3 2022Nov 21, 2022
Q2 2022Aug 15, 2022
Q1 2022May 13, 2022
Q4 2021Mar 31, 2022
Q3 2021Nov 19, 2021
Q2 2021Aug 16, 2021
Quarter to Mar 31, 2021May 24, 2021

Open Events

Decks

DeckKindSlidesDate
IPO Roadshow (June 2024)IPO roadshow24 slidesJun 26, 2024
SPAC Merger (June 2023)SPAC merger25 slidesJun 9, 2023
SPAC Merger (February 2023)SPAC merger47 slidesFeb 10, 2023

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue15.2M32.1M53.5M64.2M38.2M
Cost of revenue5.66M10.6M12.0M13.5M9.05M
Gross profit9.57M21.5M41.5M50.7M29.2M
Research and development7.57M17.4M27.7M17.0M5.73M
Selling, general and administrative21.4M28.4M46.0M15.4M8.82M
Operating income-30.2M-50.2M-79.1M-32.0M-12.5M-5.17K
Depreciation and amortization983.0K997.0K746.0K895.0K707.0K21
EBITDA-29.2M-49.2M-78.3M-31.1M-11.8M-5.15K
Interest expense02.26M10.6M4.43M3.67M
Income before tax-28.7M-6.48M-82.6M-37.6M-12.4M-5.17K
Income tax74.0K718.0K264.0K143.0K3.11M-206.3K
Net income-28.8M-7.20M-82.8M-37.7M-12.4M-5.17K
Earnings per share, basic-3.81-3.20-59.38-37.75-43.08-0.02
Earnings per share, diluted-3.81-3.20-59.38-37.75

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents5.41M15.4M38.0M7.68M25.8M47.1K
Receivables3.95M7.13M18.2M29.3M6.83M
Inventory2.67M3.40M6.17M3.87M2.71M
Current assets12.8M27.2M64.8M43.4M37.3M47.1K
Property, plant and equipment1.37M2.47M3.38M2.38M
Total assets15.8M32.8M71.7M51.4M39.4M330.0K
Accounts payable3.57M6.57M10.4M5.81M1.62M
Current liabilities38.4M18.9M65.4M75.9M31.6M310.1K
Long-term debt035.7M3.10M2.00M
Total debt071.4M38.6M56.5M26.1M170.0K
Total liabilities93.0M110.8M143.0M83.7M73.6M310.1K
Shareholders' equity-77.2M-78.0M-71.3M-32.3M-34.3M19.8K
Shares outstanding12.3M2.71M1.91M1.08M287.5K287.5K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-28.9M-42.3M-64.0M-47.0M-14.3M-35
Capital spending0-611.0K-1.61M-1.55M-912.0K-5
Free cash flow-28.9M-42.9M-65.6M-48.5M-15.2M-40
Cash from investing-611.0K-1.61M-1.55M-912.0K
Cash from financing19.0M20.2M96.0M30.5M28.9M47.1K
Dividends paid-132.0K
Share buybacks-776.5M
Change in cash-9.98M-22.7M30.4M-18.0M13.7M47.1K

Open Financials

Cap table

Built by 6ix from Allurion Technologies, Inc.’s releases

Common shares
607,651
Fully diluted
607,651

Fully diluted

LineShares
Common shares607,651

Share count over time

CountShares
Nov 22, 2026607,651

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Nicholas Lewin
Other companies: Establishment Labs Holdings Inc. (Director · Since at least Jul 18, 2018); Cutera Inc (Director · May 19, 2023 – Oct 24, 2024 · Past)
Director · Since at least Aug 1, 2023
Brendan Gibbons
Other companies: Acushnet Holdings Corp. (See Remarks · Dec 18, 2020 – Jun 18, 2021 · Past)
Chief Legal Officer · Since at least Jan 29, 2024
Michael Davin
Other companies: Cynosure Inc (Chairman, President and CEO, Director · Dec 31, 2015 – Mar 22, 2017 · Past)
Director · Since at least Aug 1, 2023
Roderick Wong
Other companies: Rocket Pharmaceuticals, Inc. (Director · Since at least Jun 13, 2024)
Director · Since at least Apr 16, 2025
Benoit ChardonChief Commercial Officer · Aug 1, 2023 – Dec 12, 2023 · Past
Douglas HudsonDirector · Since at least Nov 5, 2026
Keith JohnsDirector · Since at least Nov 5, 2026
Krishna K. GuptaDirector · Since at least Nov 5, 2026
Ojas A. BuchChief Operating Officer · Since at least Nov 5, 2026
Omar IshrakBoard Member · Since at least Nov 4, 2026
All 13 people
PersonSeat
Ram Chuttani M.DChief Medical Officer and Founding Partner · Since at least Nov 5, 2026
R. Jason RicheyDirector · Since at least Nov 5, 2026
Shantanu GaurChief Executive Officer and Co-Founder · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Allurion Technologies, Inc.